Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Sound Bioventures is a venture capital fund founded by Casper Breum and Johan Kördel, based in Malmö, Sweden. The firm operates as a registered alternative investment fund under the Swedish Alternative Investment Funds Managers Act. It focuses on investing in clinical and preclinical stage private companies in Europe and the USA.
Sound Bioventures invests in companies entering the clinical stage of drug development, specifically targeting novel therapeutic areas. The firm avoids incremental innovations, medical devices, digital health, and diagnostics. Investments are made across all private financing rounds, with a particular interest in companies with Scandinavian roots.
Notable portfolio companies include Aboleris Pharma, developing immune tolerance therapies; AnaCardio, focused on heart failure treatments; and Theolytics, working on oncolytic viruses for cancer. Other companies include Artax Biopharma, BOOST Pharma, and Breye Therapeutics, all in various stages of clinical development.
Email info@soundbioventures.com with your deck to pitch them.
Yes, Sound Bioventures is open to leading investment rounds in the companies they support.
The firm aims to support its portfolio companies through to regulatory approval, which may include follow-on investments as needed.
Specific fund size details are not disclosed, but the firm actively invests in multiple stages of funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.